Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID STEROID 2: Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia
2020-003363-25Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Rigshospitalet. Primary endpoint: Days alive without life support to day 28. Started Jul 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003363-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003363-25.